95 results
Summary of Recommendations for the Treatment of Aspergillosis - IDSA Guidelines
 - Invasive syndromes of Aspergillus
Aspergillosis - IDSA ... or colonizing syndromes ... Aspergillosis #Treatment ... #pharmacology # ... #medications #IDSA
Incomplete Spinal Cord Syndromes
Anterior Cord Syndrome:
 • Bilateral loss of motor, pain and temperature sensation below
Incomplete Spinal Cord Syndromes ... Anterior Cord Syndrome ... sensation below level ... Central Cord Syndrome ... #Incomplete #SpinalCord
IDSA Aspergillosis Treatment
 • Invasive pulmonary aspergillosis (IPA)
 • CNS aspergillosis
 • Cardiac Aspergillus infection
 •
IDSA Aspergillosis ... Treatment • Invasive ... Aspergillosis #Treatment ... #management #pharmacology ... #IDSA
IDSA Treatment of Necrotizing Infections of the Skin, Fascia, and Muscle
 • Mixed infections
 • Streptococcus
IDSA Treatment of ... fasciitis #Skin #IDSA ... #Treatment #management ... #antibiotics #pharmacology
Acute Spinal Cord Injuries: Pathogenesis and clinical findings
 • Anterior Cord Syndrome -> Anterior spinal artery
Anterior Cord Syndrome ... function below injury level ... • Central Cord Syndrome ... and #Acute #SpinalCord ... #Injury #Syndromes
Back to the "10 Need to Know" series - Drug Therapeutic Target Levels. 

For lithium, target
Therapeutic Target Levels ... lithium, target levels ... vary depending on treatment ... mortality at a higher level ... Ranges #Toxicology #Pharmacology
Parenteral Antimicrobial Treatment of Common Microorganisms Causing Native Vertebral Osteomyelitis - IDSA 
Staphylococci, oxacillin susceptible
Staphylococci, oxacillin
Antimicrobial Treatment ... Osteomyelitis - IDSA ... Osteomyelitis #management #treatment ... #pharmacology # ... idsa
IDSA - Doses of Drugs for Treatment of Adults and Children with Multidrug-Resistant Tuberculosis
Step 1 Levofloxacin,
IDSA - Doses of ... Drugs for Treatment ... MDRTB #management #Treatment ... antimicrobials #pharmacology ... #dosing #idsa #
Outpatient Treatment of with Community-Acquired Pneumonia (CAP)
No comorbidities or risk factors for MRSA or Pseudomonas aeruginosa:
Outpatient Treatment ... fluoroquinolone #IDSA ... #Antibiotics #Treatment ... Management #Guidelines #pharmacology
IBS-C Pharmacotherapy

Polyethylene glycol
Lubiprostone
Linaclotide
Plecanatide
Tegaserod
Tenapanor

#IBSC #IBS #Constipation #Irritable #Bowel #Syndrome #pharmacology #table #comparison #management #treatment
Irritable #Bowel #Syndrome ... #pharmacology # ... comparison #management #treatment